# Molecular Regulation of Muscle Glucose Metabolism

> **NCT01581736** · PHASE1 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 48 (actual)

## Conditions studied

- Obesity
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** U100 Humulin
- **OTHER:** Exercise

## Key facts

- **NCT ID:** NCT01581736
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** PI job change
- **Last updated:** 2017-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01581736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01581736, "Molecular Regulation of Muscle Glucose Metabolism". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01581736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
